AESEG - Asociacion Española de Medicamentos Genéricos

Did you know?
A generic and a branded medicine have the same active substance and, therefore, they are interchangeable »
A generic medicine has the same quality, efficacy and safety as the original product »
Generic medicines can reduce the price of an innovator product up to 60% »
Generic medicines cost less because there has been no investment to discover them »
The first generic medicine commercialised in Spain was the AZT or Zidovudina for the treatment of HIV »
The use of generic medicines in the National Public Health departments is increasing »
You differentiate a generic because it has the name of the active substance and the letters EFG on its label »
Versión EspañolaRSS

14th Pharmaceutical Forum. New Times - New Strategies

  • Print

AESEG - October 2011

Open document »

Generic Pharmaceutical Industry: chronology of a case study

  • Print

AESEG - May 2011

Open document »

Workshop Journalists – Generics Market

  • Print

AESEG/IMS - November 2010

Open document »

Generic Medicines: Essential contributors to the long-term health of society

  • Print

IMS - April 2010

Open document »

Industry and generic market in Spain (Merida)

  • Print

Solchaga Recio & Asociados/AESEG - December 2009

Open document »
Open summary »

UE Pharmaceutical Sector Inquiry

  • Print

Solchaga Recio & Asociados/AESEG - November 2009

Open document »

Industry and generic market in Spain

  • Print

Solchaga Recio & Asociados/AESEG - October 2009

Openr document »

Pharmaceutical Sector Inquiry

  • Print

 

European Commission - July 2009

Communication »
Commission Staff Working Document (part 1) »
Commission Staff Working Document (part 2) »
Citizens' summary »
Press Release - Antitrust: shortcomings in pharmaceutical sector require further action »
Frequently asked questions on final report of sector inquiry into pharmaceuticals »
Fact sheet 1 » - Fact sheet 3 » - Fact sheet 3 »

UE Pharmaceutical Sector Inquiry: the case of Spain

  • Print

Solchaga Recio & Asociados/AESEG - February 2009

Open document »

EGA Report on Patent-related Barriers

  • Print

EGA/AESEG - Deicember 2008

Open document »

Economic impact of a retroactive change in the regulation of pharmaceutical patents

  • Print

Solchaga Recio & Asociados/AESEG - November 2008

Open document »
Open graphics »

Global Pharmaceutical Perspectives - Intelligence.360

  • Print

IMS - June 2008

Open document »

Toolkit for substitution by the pharmacist

  • Print

January 2008

Open document »

Study on knowledge and attitude toward generics

  • Print

SIGMADOS - January 2008

Open document »

First Sector Study on the Perception of Generic Drugs

  • Print

AMERKA STAR/AESEG - October 2005

Open document »

You are here: Home Studies and reports





Generic Medicines EFG
 Spanish Generic Medicines Association
New address
Velázquez, 54 - 3º
28001 - Madrid - España
T. +34 91 572 12 62
F. +34 91 571 34 20


European Generic Medicines Association


Spanish Agency of Medicines and Sanitary Products